Products

LumiNE US
Augmedit (LumiNE US)
Neurology AI
LumiNE US by Augmedit B.V. is an AI-powered augmented reality software that transforms 2D MRI and CT scans into 3D models for enhanced neurosurgical planning and visualization.

See all 1 product →

About Augmedit (LumiNE US)

Augmedit (LumiNE US) is a healthcare AI company specializing in augmented reality (AR) software for surgical planning and guidance. Their core mission is to provide safe, reliable, and affordable holograms to enhance individualized treatment plans, facilitate more effective surgical procedures, and improve medical staff training and patient education.

The company’s flagship product, LumiNE US, converts 2D MRI and CT scans into interactive 3D holographic models. This allows physicians, particularly neurosurgeons and qualified medical professionals, to visualize anatomy and pathology with enhanced insights during the surgical preparation phase. The software utilizes AI-based algorithms for semi-automatic segmentation of structures like tumors, brain, skin, and ventricles from contrast-enhanced MR scans, and a threshold-based approach for CT scans. It is important to note that LumiNE US is intended for surgical planning and visualization, not for diagnostic use.

Augmedit’s technology aims to integrate seamlessly into existing surgical workflows, offering a low-priced subscription model and hardware agnostic compatibility, including with HoloLens 2. Beyond planning, their LumiNE Elite software is designed for intra-operative use, projecting holograms onto the patient in the operating room to guide surgeons and potentially lead to improved patient outcomes and cost savings.

Focus Areas

augmented reality surgery surgical navigation neurosurgery surgical visualization medical AR software as a medical device (SaMD) intraoperative guidance 3D holographic visualization surgical planning anatomical segmentation digital surgery medtech surgical robotics medical imaging software

Business Intelligence

Technologycloud-based platform, Microsoft HoloLens 2, AI-based segmentation (nnUnet)

What Physicians Need to Know

Augmented Reality Surgical Planning
Augmedit's LumiNE US software converts 2D MRI and CT scans into 3D holographic models for surgical planning, providing an immersive AR-based visualization of patient data via wireless Head-Mounted Displays (HMDs). This aids neurosurgeons and other medical professionals in understanding anatomy and pathology before surgery.
AI-Powered Segmentation
The LumiNE US software utilizes AI-based algorithms for semi-automatic segmentation of known tumors, brain structures, skin, and ventricles from contrast-enhanced MR scans, and a threshold-based segmentation for CT scans. This enhances the detail and accuracy of the 3D models.
FDA Cleared for Surgical Planning
Augmedit's LumiNE US software received FDA clearance in September 2024 for use in surgical planning, specifically for visualizing anatomy and pathology in preparation for surgical treatment.
Intraoperative Guidance (European Market)
Augmedit also offers LumiNE Elite, available in the European market, which registers generated holograms onto the patient's head for intraoperative visualization, particularly for procedures like placing an External Ventricular Drain (EVD).
Streamlined Workflow
The LumiNE US software is tailored for neurosurgeons, residents, and qualified medical professionals within hospital settings, aiming to enrich existing surgical workflows with intuitive Augmented Reality.
Hardware Agnostic
Augmedit's solutions are designed to be hardware agnostic, compatible with devices like Microsoft HoloLens 2, and with web and mobile versions coming soon.
Patient Education & Shared Decision Making
The patient-specific 3D holograms can enhance patient understanding and engagement, leading to improved patient-clinician communication and supporting shared decision-making.
Physician Tip

Augmedit's LumiNE US offers neurosurgeons and other medical professionals an intuitive AR-based system to convert 2D MRI and CT scans into interactive 3D holographic models for enhanced surgical planning. This allows for a deeper understanding of complex anatomy and pathology before entering the operating room, potentially reducing errors and improving patient outcomes. The AI-powered segmentation further refines these models, providing precise visualization of critical structures. While LumiNE US is currently cleared for surgical *planning* in the US, the company's broader offerings in Europe, like LumiNE Elite, demonstrate their potential for intraoperative guidance. The hardware-agnostic approach and cloud-based platform offer flexibility in integration. Physicians should note that LumiNE US is intended for visualization in preparation for surgery and not for diagnostic purposes.

Augmedit's LumiNE US uses a cloud-based platform to connect DICOM images and is designed to be compatible with wireless Head-Mounted Displays (HMDs) such as Microsoft HoloLens 2. The system facilitates the conversion of 2D patient imaging into 3D models and allows for the storage and navigation of patient images within a secure cloud environment.

Products by Augmedit (LumiNE US)

1 product in the directory

LumiNE US
Augmedit (LumiNE US)
Neurology AI
LumiNE US by Augmedit B.V. is an AI-powered augmented reality software that transforms 2D MRI and CT scans into 3D models for enhanced neurosurgical planning and visualization.

What the Web Says

Augmedit (LumiNE US) develops software for visualizing medical images and converting 2D scans into 3D models for surgical preparation, including augmented reality features. Reviews for "LumiNE US" specifically are limited, but there are reviews for other companies with similar names like "Augmedix" (a healthcare AI documentation company) and various "Lumine" or "Lumin" skincare/product companies. It's important to distinguish between these different entities when evaluating feedback. The available information for Augmedit (LumiNE US) focuses on its FDA clearance and technical specifications rather than user reviews.

Overall: Mixed

Strengths

  • LumiNE US software is intended for visualization of medical images to provide insights in anatomy and pathology in preparation of surgical treatment.
  • The software allows for the conversion of 2D patient imaging into 3D models and for the visualization of 2D and 3D patient imaging, including Augmented Reality.
  • LumiNE US can be used for contrast-enhanced T1 MR scans (semi-automatic segmentation of known tumor, skin, brain, and ventricles) or for CT scans (threshold-based segmentation).
  • The LumiNE US MRI T1 tumor segmentation function can be used for single intracranial contrast-enhancing tumors within specific volume and diameter ranges.
  • Applicable pathology includes scans with known intracranial lesions diagnosed as Glioblastoma, Meningioma, or Metastasis.

Limitations

  • When accessing the LumiNE US software from a wireless Head-Mounted Display (HMD) or PC monitor, images viewed are for informational purposes only and not intended for diagnostic use.
  • Specific user reviews for Augmedit (LumiNE US) are not readily available on common review platforms like G2, Glassdoor, Capterra, or Reddit.
  • The search results were conflated with reviews for other companies such as Augmedix (AI medical documentation) and various Lumine/Lumin skincare brands, making it difficult to find direct feedback for Augmedit (LumiNE US).

Based on reviews from: accessdata.fda.gov, Transparency Registry

Last updated: 2026-10-24

Videos

News, demos, and interviews about Augmedit (LumiNE US).

Loading videos...

Videos load interactively. If none appear, search YouTube for Augmedit (LumiNE US) →

View all on YouTube

Press & Coverage

Augmedit
Launch Announcement: LumiNE Elite Achieves CE Approval
Augmedit announced that its LumiNE Elite software, designed for intraoperative use, received CE Mark approval in January 2026, enabling its use in Europe.
2026-01
Augmedit
Augmedit Announces First Closing of Series A Round Led by Egeria Impact Investments, Joined by EIC Fund
In June 2025, Augmedit announced the initial closing of its Series A funding round, with Egeria Impact Investments as the lead investor and participation from the EIC Fund.
2025-06
Augmedit
LumiNE US Software Receives FDA Clearance for Surgical Planning
Augmedit's LumiNE US software, which converts 2D medical imaging into 3D models for surgical planning, received FDA 510(k) clearance in September 2024.
2024-09
Acta Neurochirurgica
Comparing augmented reality-assisted and freehand external ventricular drain placement: a multicenter randomized controlled crossover phantom study
A multicenter randomized controlled phantom study published in December 2025 demonstrated that AR guidance from Augmedit's technology was superior to the freehand technique for placing brain drains.
2025-12
Augmedit
Augmedit Closes Seed Investment Round
Augmedit closed a seed investment round of over €1 million in November 2022, with funding from Dutch and Swiss investors and the US-based Revere Partners Venture Capital Fund.
2022-11
Rasph
Augmedit and the EIC Accelerator: Holograms Cleared for Surgery - Rasph
This article from September 2026 details Augmedit's journey with EIC support, including obtaining FDA clearance for LumiNE US in September 2024 and CE mark for LumiNE Elite in January 2026, and a Series A funding round in June 2025.
2026-09
AuntMinnie
Automated MR image segmentation enables AR use for surgeons
An August 2021 article highlights Augmedit's cloud-based AugSafe application, which uses automatic segmentation to create 3D models from MR images for AR visualization in surgical planning, proving accurate and faster than manual methods.
2021-08

Frequently Asked Questions

Augmedit (LumiNE US) provides advanced AR surgical navigation solutions designed to enhance precision in neurosurgery. Their products offer real-time, 3D holographic visualization of patient anatomy directly within the surgeon's field of view, overlaying critical imaging data onto the patient. This integration aims to streamline surgical planning and intraoperative guidance without significantly altering established surgical workflows, providing intuitive navigation and reducing reliance on traditional 2D screens.
Augmedit's SaMD products undergo rigorous development and testing to meet stringent regulatory standards, including FDA clearance for their intended surgical applications. The company prioritizes data security and patient privacy by implementing robust cybersecurity measures, including encryption, access controls, and regular security audits, to protect sensitive medical imaging data and ensure compliance with healthcare data regulations.
Augmedit (LumiNE US) typically offers flexible pricing models that can include per-procedure fees, subscription-based licenses, or capital equipment purchases, depending on the specific product and institutional needs. They provide comprehensive ongoing support, including technical assistance, regular software updates, and extensive training programs for surgeons and surgical teams to ensure optimal utilization and proficiency with their AR and 3D holographic visualization systems.
Augmedit's technology is designed with interoperability in mind, allowing for potential integration with various surgical robotics platforms and other digital surgery solutions to create a more connected operating room ecosystem. The company actively pursues strategic partnerships with leading medtech companies and surgical robotics manufacturers to expand compatibility and enhance the overall digital surgery experience.
Augmedit (LumiNE US) envisions a future where AR and 3D holographic visualization become standard tools in surgical practice, continuously enhancing precision, safety, and efficiency across multiple specialties. The company demonstrates strong financial stability, supported by successful funding rounds and increasing adoption of its innovative solutions in the medtech market, indicating a positive growth trajectory and commitment to long-term development in surgical visualization and intraoperative guidance.

Related Companies

Perimeter Medical Imaging AI is a medical technology company dedicated to transforming cancer surgery through the use of ultra-high-resolution, real-time, advanced imaging tools. The company’s mission is to address significant unmet medical needs in cancer surgery, particularly concerning positive margins and the resulting need for re-excisions. Their proprietary technology, including the S-Series Optical Coherence Tomography […]

SOPHiA GENETICS is a healthcare AI company that has developed a cloud-native, AI-driven SaaS platform called SOPHiA DDM™. This platform is designed to enable hospitals, clinical laboratories, academic medical centers, and biopharmaceutical companies to analyze and interpret complex genomic, radiomic, and multimodal healthcare data. The company’s mission is to democratize data-driven medicine, providing actionable insights […]

Koios Care is a neurology-focused digital medicine company based in Antwerp, Belgium, specializing in AI-powered platforms. The company aims to revolutionize the management of neurological and chronic conditions, with an initial focus on Parkinson’s Disease. Koios Care’s platform utilizes everyday devices like smartphones and smartwatches to passively collect and analyze data, transforming it into objective, […]

Qure.ai is a leading healthcare AI company that leverages deep learning and artificial intelligence to revolutionize medical imaging diagnostics and make healthcare more accessible and affordable globally. The company develops AI-powered solutions for interpreting X-rays and CT scans, addressing critical health needs in areas such as lung, musculoskeletal, cardiovascular, and neurocritical health. Their technology assists […]

Deep Bio is a healthcare AI company that develops deep learning-based cancer diagnostic support software, aiming to advance patient outcomes by empowering clinicians with innovative technology. Their mission is to provide tools that enable medical professionals to make critical decisions, ultimately enhancing healthcare delivery and allowing clinicians to focus more on patient care. The company’s […]

CortiCare is a healthcare AI company specializing in neuro telemetry and remote patient monitoring, primarily focusing on electroencephalogram (EEG) services. The company provides telehealth services and an EEG brain monitoring platform to neurology and critical care areas within hospitals, including ICUs, NICUs, PICUs, and EMUs. Their services aim to enhance the neurological assessment of adult, […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.